Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Propofol: pro- or anticonvulsant?

A Borgeat1

  • 1Department of Orthopaedics, Klinik Balgrist, University of Zurich, Switzerland.

European Journal of Anaesthesiology. Supplement
|May 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CCR5 tyrosine sulfation heterogeneity generates cell surface receptor subpopulations with different ligand binding properties.

Biochimica et biophysica acta. General subjects·2020
Same author

Lidocaine inhibits cytoskeletal remodelling and human breast cancer cell migration.

British journal of anaesthesia·2018
Same author

Prevention of arterial hypotension after spinal anaesthesia using vena cava ultrasound to guide fluid management.

British journal of anaesthesia·2018
Same author

Parecoxib, propacetamol, and their combination for analgesia after total hip arthroplasty: a randomized non-inferiority trial.

Acta anaesthesiologica Scandinavica·2016
Same author

Archives of gynecology and obstetrics·2016
Same author

Clinically relevant concentrations of lidocaine and ropivacaine inhibit TNFα-induced invasion of lung adenocarcinoma cells in vitro by blocking the activation of Akt and focal adhesion kinase.

British journal of anaesthesia·2015
Same journal

EuroNeuro 2010. Abstracts of the 6th EuroNeuro Congress. Porto, Portugal. February 4-6, 2010.

European journal of anaesthesiology. Supplement·2010
Same journal

Euroanaesthesia 2003. Abstracts of the joint meeting of the European Society of Anaesthesiologists and European Academy of Anaesthesiology, Confederation of European National Societies of Anaesthesiology, and Association of Anaesthetists of Great Britain & Ireland. May 31-June 3, 2003. Glasgow, Scotland.

European journal of anaesthesiology. Supplement·2008
Same journal

Evoked potentials in the ICU.

European journal of anaesthesiology. Supplement·2008
Same journal

Intracranial pressure monitoring.

European journal of anaesthesiology. Supplement·2008
Same journal

Phrenic nerve stimulation.

European journal of anaesthesiology. Supplement·2008
Same journal

Direct stimulation: a useful technique.

European journal of anaesthesiology. Supplement·2008
See all related articles

Propofol

Area of Science:

  • Anesthesiology and Pharmacology
  • Neuroscience

Background:

  • The anticonvulsant properties of propofol are debated, with conflicting reports of pro- and anticonvulsant effects.
  • While some case studies suggest proconvulsant activity, systematic research indicates propofol has antiepileptic effects.

Purpose of the Study:

  • To clarify the controversial role of propofol in seizure activity.
  • To consolidate evidence regarding propofol's effects on epilepsy.

Main Methods:

  • Review of systematic studies in humans and animals.
  • Analysis of propofol's effects during electroconvulsive therapy.
  • Examination of propofol's efficacy in refractory status epilepticus and animal epilepsy models.

Main Results:

Related Experiment Videos

  • Propofol consistently reduces seizure duration in electroconvulsive therapy.
  • Successful control of refractory status epilepticus has been reported with propofol use.
  • Propofol demonstrates significant protection against induced epilepsy in animal models.

Conclusions:

  • Systematic evidence strongly supports propofol's antiepileptic properties.
  • Propofol's benefits may stem from CNS depression, enhanced GABAergic inhibition, and reduced excitatory neurotransmitter release.